Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.16 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)
• TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'